Cipla Ltd
NSE:CIPLA

Watchlist Manager
Cipla Ltd Logo
Cipla Ltd
NSE:CIPLA
Watchlist
Price: 1 486.5 INR 1.75% Market Closed
Market Cap: 1.2T INR
Have any thoughts about
Cipla Ltd?
Write Note

Relative Value

The Relative Value of one CIPLA stock under the Base Case scenario is 1 527.37 INR. Compared to the current market price of 1 486.5 INR, Cipla Ltd is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CIPLA Relative Value
Base Case
1 527.37 INR
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
12
vs Industry
28
Median 3Y
3.9
Median 5Y
3.6
Industry
2.5
Forward
4.2
vs History
82
vs Industry
16
Median 3Y
29.6
Median 5Y
29.5
Industry
21.9
Forward
25.2
vs History
28
vs Industry
15
Median 3Y
25.7
Median 5Y
22.6
Industry
16.5
vs History
55
vs Industry
11
Median 3Y
53.8
Median 5Y
51.2
Industry
23.6
vs History
20
vs Industry
16
Median 3Y
4
Median 5Y
3.9
Industry
2.1
vs History
12
vs Industry
27
Median 3Y
3.7
Median 5Y
3.5
Industry
2.6
Forward
3.9
vs History
25
vs Industry
31
Median 3Y
5.9
Median 5Y
5.7
Industry
5.2
vs History
42
vs Industry
21
Median 3Y
16.5
Median 5Y
16.4
Industry
13.3
Forward
15.8
vs History
71
vs Industry
20
Median 3Y
20.8
Median 5Y
20.9
Industry
16.6
Forward
18.1
vs History
28
vs Industry
16
Median 3Y
23.8
Median 5Y
20.6
Industry
15.6
vs History
26
vs Industry
11
Median 3Y
36.4
Median 5Y
28.4
Industry
19.1
vs History
15
vs Industry
17
Median 3Y
4.1
Median 5Y
3.8
Industry
1.9

Multiples Across Competitors

CIPLA Competitors Multiples
Cipla Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Cipla Ltd
NSE:CIPLA
1.2T INR 4.5 26.8 16.7 19.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
Cipla Ltd
NSE:CIPLA
Average P/E: 31.7
26.8
31%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top